Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Alzheimer's Disease

  Free Subscription

Articles published in Rev Neurol

Retrieve available abstracts of 8 articles:
HTML format

Single Articles

    January 2024
  1. MORALES-CASADO MI, Diezma-Martin AM, Munoz-Escudero F, Ronsenstone-Calvo S, et al
    Association between myasthenia gravis and Alzheimer's disease.
    Rev Neurol. 2024;78:41-46.
    PubMed     Abstract available

    March 2023
    [Lecanemab in Alzheimer's disease: are we really before a shift in the prognosis of the disease?].
    Rev Neurol. 2023;76:185-188.

    October 2022
  3. POUDEVIDA S, de Sola S, Brugulat-Serrat A, Mas-Vall Llosera G, et al
    [Effectiveness of a psychotherapeutic intervention group program in the improvement of caregiver well-being in Alzheimer's disease patients' family caregivers: the CuiDem study].
    Rev Neurol. 2022;75:203-211.
    PubMed     Abstract available

    April 2022
  4. LABOS E, Guajardo ME, Soderlund ME, Pagotto V, et al
    [Vascular damage and cognitive-functional performance in a population with mild cognitive impairment].
    Rev Neurol. 2022;74:209-218.
    PubMed     Abstract available

    March 2022
  5. DAL-RE R
    [The European Medicines Agency rejects the authorization of aducanumab for Alzheimer's disease].
    Rev Neurol. 2022;74:207-208.

    October 2021
  6. DAL-RE R
    [Aducanumab approval for Alzheimer's disease in the USA: the surrender of science].
    Rev Neurol. 2021;73:296-297.

    June 2021
  7. MONGE-GARCIA V, Llorca-Tolon L, Gasparini-Berenguer R, Monge-Argiles JA, et al
    [Role of the Ass1-42/Ass1-40 ratio in the concept 'Alzheimer's disease contributes to mild cognitive impairment'].
    Rev Neurol. 2021;72:371-376.
    PubMed     Abstract available

    November 2020
  8. DEVI-BASTIDA J, Catala-Sune N, Jofre-Font S
    [Bilingualism as a factor in the protection of Alzheimer's disease: a systematic review].
    Rev Neurol. 2020;71:353-364.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.